T32 Training Grant in Translational Immunology
T32 转化免疫学培训补助金
基本信息
- 批准号:10269999
- 负责人:
- 金额:$ 16.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
This new T32 program is designed to provide a rigorous training program in translational
immunology for 2 pre-doctoral and one post-doctoral candidate. It will recruit a diverse cadre of
young scientists to careers in immune disease-focused investigation and equip them for
success. An increasing awareness of the role of the immune system in multiple diseases,
coupled with technologic advances that allow analysis of microscopic quantities of human
specimens have fueled exponential growth in the exploration and understanding of human
immunopathologic conditions. Nevertheless, effective therapies for many immune disorders are
still lacking. Highly motivated individuals completing training programs in immunology,
particularly physician-scientists, are needed to enable rigorous and creative advances in
biomedical research that will enhance our understanding of disease pathogenesis and suggest
strategies to improve the outcome of patients with immune disorders. Our proposal engages 21
mentors at all career levels and is built around 4 areas of scientific excellence in immunology: 1)
Autoimmunity; 2) Neuroimmune inflammation; 3) Tissue injury, inflammation and innate
immunity and 4) Tumor immunology. In each area, our faculty investigate disease mechanisms
using specimens from well-established clinical cohorts and biorepositories and perform human-
relevant studies that range from focused studies in model organisms to clinical trials of novel
therapies. Specific aims are:
1. To recruit trainees who are diverse with respect to demographics, experience and interests;
2. To provide a multi-disciplinary “toolbox” curriculum needed for a successful career in human
and translational investigation;
3. To teach trainees how to conduct creative, rigorous and ethical independent research that is
driven by observations in human disease and that uses state of the art technologies to generate
and test new hypotheses related to immune mediated diseases;
4. To engage faculty, students and our advisory committee in an ongoing self-evaluation
process that will foster the continued growth and improvement of our training program;
5. To mentor and create a new generation of translational immunologists who will collaboratively
tackle research problems linked to improving clinical outcomes of patients with immune-
mediated diseases.
By combining existing courses that are part of the established infrastructure of the Elmezzi
Graduate Program in Molecular Medicine and the Zucker School of Medicine at Hofstra
University-Northwell Health with new curricular elements designed for this training program,
including programs in leadership, conflict resolution, resilience and more, we can provide an
enriched and motivating experience for our trainees. In this fashion we will develop physician-
scientists and translational investigators who are focused on human disease and equipped with
a broad understanding of immunology, modern technologies and the resilience to persevere.
这个新的 T32 计划旨在提供严格的翻译培训计划
免疫学 2 名博士前和 1 名博士后候选人 它将招募多元化的骨干人员。
年轻科学家从事以免疫疾病为重点的研究,并为他们做好准备
成功地认识到免疫系统在多种疾病中的作用,
再加上技术进步,可以分析人类的微观数量
标本推动了人类探索和理解的指数级增长
然而,许多免疫疾病的有效疗法仍然存在。
仍然缺乏积极主动的个人完成免疫学培训课程,
特别是医师科学家,需要在以下方面取得严格和创造性的进步
生物医学研究将增强我们对疾病发病机制的理解并提出建议
我们的提案涉及 21 名患者。
各个职业级别的导师,围绕免疫学领域的 4 个卓越科学领域建立:1)
自身免疫;2)神经免疫炎症;3)组织损伤、炎症和先天性疾病;
免疫学和 4) 肿瘤免疫学 在每个领域,我们的教师都研究疾病机制。
使用来自完善的临床队列和生物样本库的样本,并进行人类-
相关研究范围从模式生物的重点研究到新型药物的临床试验
具体目标是:
1. 招募在人口统计、经验和兴趣方面多样化的学员;
2. 提供人类成功职业生涯所需的多学科“工具箱”课程
和转化研究;
3. 教导学员如何进行创造性、严谨和符合道德的独立研究
由对人类疾病的观察驱动,并使用最先进的技术来产生
并测试与免疫介导疾病相关的新假设;
4. 让教师、学生和我们的咨询委员会参与持续的自我评估
将促进我们培训计划持续发展和改进的流程;
5. 指导和培养新一代转化免疫学家,他们将合作
解决与改善免疫缺陷患者临床结果相关的研究问题
介导的疾病。
通过现有的组合课程,这些课程是 Elmezzi 现有基础设施的一部分
分子医学研究生项目和霍夫斯特拉扎克医学院
诺斯韦尔健康大学为此培训项目设计了新的课程内容,
包括领导力、冲突解决、复原力等方面的计划,我们可以提供
通过这种方式,我们将为我们的学员培养丰富且激励人心的经验。
专注于人类疾病并配备了
对免疫学、现代技术和坚持不懈的韧性有广泛的了解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anne Davidson其他文献
Anne Davidson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anne Davidson', 18)}}的其他基金
Dissecting the heterogeneity and function of myeloid cells in lupus nephritis
剖析狼疮性肾炎骨髓细胞的异质性和功能
- 批准号:
10588862 - 财政年份:2023
- 资助金额:
$ 16.73万 - 项目类别:
T32 Training Grant in Translational Immunology
T32 转化免疫学培训补助金
- 批准号:
10470893 - 财政年份:2021
- 资助金额:
$ 16.73万 - 项目类别:
Mechanisms for Human TLR8 induced pregnancy loss in a mouse model of SLE
人 TLR8 诱导 SLE 小鼠模型妊娠失败的机制
- 批准号:
10301657 - 财政年份:2021
- 资助金额:
$ 16.73万 - 项目类别:
T32 Training Grant in Translational Immunology
T32 转化免疫学培训补助金
- 批准号:
10653079 - 财政年份:2021
- 资助金额:
$ 16.73万 - 项目类别:
Mechanisms for Human TLR8 induced pregnancy loss in a mouse model of SLE
人 TLR8 诱导 SLE 小鼠模型妊娠失败的机制
- 批准号:
10434117 - 财政年份:2021
- 资助金额:
$ 16.73万 - 项目类别:
Induction of lupus-related autoantibodies by TNF inhibitors
TNF 抑制剂诱导狼疮相关自身抗体
- 批准号:
10405223 - 财政年份:2021
- 资助金额:
$ 16.73万 - 项目类别:
Heterogeneous pathways to autoantibody production: implications for prognosis and therapeutic targeting
自身抗体产生的异质途径:对预后和治疗靶向的影响
- 批准号:
10159859 - 财政年份:2019
- 资助金额:
$ 16.73万 - 项目类别:
相似国自然基金
基于不同纳米颗粒递送系统的C型产气荚膜梭菌毒素表位肽疫苗的设计及免疫学评价
- 批准号:32360882
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
抗MDA5自身抗体促进皮肌炎快速进展间质性肺炎的免疫学机制研究
- 批准号:82371804
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
病原体感染触发视神经脊髓炎谱系疾病(NMOSD)的免疫学机制研究
- 批准号:32300747
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
组织蛋白酶E增强MIBC新辅助免疫化疗应答的免疫学机制研究
- 批准号:82373236
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
异常激活的小胶质细胞通过上调CTSS抑制微血管特异性因子MFSD2A表达促进1型糖尿病视网膜病变的免疫学机制研究
- 批准号:82370827
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
23rd Annual Rocky Mountain Virology Association Conference
第 23 届落基山病毒学协会年度会议
- 批准号:
10753094 - 财政年份:2023
- 资助金额:
$ 16.73万 - 项目类别:
Cancer Therapeutics and Host Response Research Program
癌症治疗和宿主反应研究计划
- 批准号:
10625756 - 财政年份:2023
- 资助金额:
$ 16.73万 - 项目类别:
Washington University (WU) ROBIN Center: MicroEnvironment and Tumor Effects Of Radiotherapy (METEOR)
华盛顿大学 (WU) 罗宾中心:放射治疗的微环境和肿瘤效应 (METEOR)
- 批准号:
10715019 - 财政年份:2023
- 资助金额:
$ 16.73万 - 项目类别: